{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:49:04Z","timestamp":1793875744295,"version":"4.7.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,8]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Risk assessment is crucial in patients with CMML because survival may range from a few months to several years. Integrating clinical features, morphology, and genetic lesions significantly improves risk stratification in CMML.<\/jats:p>","DOI":"10.1182\/blood-2016-05-714030","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T21:59:02Z","timestamp":1467842342000},"page":"1408-1417","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":349,"title":["Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia"],"prefix":"10.1182","volume":"128","author":[{"given":"Chiara","family":"Elena","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy;"},{"name":"Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gall\u00ec","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Such","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manja","family":"Meggendorfer","sequence":"additional","affiliation":[{"name":"Munich Leukemia Laboratory GmbH, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Germing","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Cervera","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Molteni","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Fasan","sequence":"additional","affiliation":[{"name":"Munich Leukemia Laboratory GmbH, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Schuler","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ambaglio","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lopez-Pavia","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Zibellini","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kuendgen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Travaglino","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyes","family":"Sancho-Tello","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Arnau de Vilanova, Valencia, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Catrical\u00e0","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Vicente","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital de La Ribera, Alzira, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[{"name":"Munich Leukemia Laboratory GmbH, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Haferlach","sequence":"additional","affiliation":[{"name":"Munich Leukemia Laboratory GmbH, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo F.","family":"Sanz","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Malcovati","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy;"},{"name":"Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy;"},{"name":"Department of Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111902453251600_B1","first-page":"18","article-title":"Introduction and overview of the classification of the myeloid neoplasms.","volume-title":"WHO Classification of Tumors Of Haematopoietic and Lymphoid Tissues","author":"Vardiman","year":"2008"},{"key":"2019111902453251600_B2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/asheducation-2011.1.264","article-title":"Myelodysplastic\/myeloproliferative neoplasms.","volume":"2011","author":"Cazzola","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"2019111902453251600_B3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","article-title":"The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia.","volume":"87","author":"Bennett","year":"1994","journal-title":"Br J Haematol"},{"key":"2019111902453251600_B4","first-page":"49","article-title":"Chronic myelomonocytic leukaemia.","volume-title":"WHO Classification of Tumors Of Haematopoietic and Lymphoid Tissues","author":"Vardiman","year":"2008"},{"issue":"20","key":"2019111902453251600_B5","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2019111902453251600_B6","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3324\/haematol.11051","article-title":"Chronic myelomonocytic leukemia in the light of the WHO proposals.","volume":"92","author":"Germing","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"2019111902453251600_B7","first-page":"52","article-title":"Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.","volume":"6","author":"Aul","year":"1992","journal-title":"Leukemia"},{"issue":"1","key":"2019111902453251600_B8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2141.1988.tb04173.x","article-title":"Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival.","volume":"68","author":"Worsley","year":"1988","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111902453251600_B9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.","volume":"99","author":"Onida","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2019111902453251600_B10","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes.","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"issue":"12","key":"2019111902453251600_B11","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes.","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2019111902453251600_B12","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/leu.2013.88","article-title":"Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes [published correction appears in Leukemia. 2013;27(10):2112].","volume":"27","author":"Patnaik","year":"2013","journal-title":"Leukemia"},{"issue":"15","key":"2019111902453251600_B13","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood-2012-08-452938","article-title":"Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.","volume":"121","author":"Such","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2019111902453251600_B14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2010.030957","article-title":"Cytogenetic risk stratification in chronic myelomonocytic leukemia.","volume":"96","author":"Such","year":"2011","journal-title":"Haematologica"},{"issue":"24","key":"2019111902453251600_B15","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","article-title":"Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1.","volume":"28","author":"Kohlmann","year":"2010","journal-title":"J Clin Oncol"},{"issue":"15","key":"2019111902453251600_B16","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2012-01-404863","article-title":"SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).","volume":"120","author":"Meggendorfer","year":"2012","journal-title":"Blood"},{"issue":"22","key":"2019111902453251600_B17","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes.","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2019111902453251600_B18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng.2495","article-title":"Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.","volume":"45","author":"Piazza","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"2019111902453251600_B19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1182\/blood-2014-06-579466","article-title":"Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.","volume":"125","author":"Gambacorti-Passerini","year":"2015","journal-title":"Blood"},{"issue":"19","key":"2019111902453251600_B20","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","article-title":"Prognostic score including gene mutations in chronic myelomonocytic leukemia.","volume":"31","author":"Itzykson","year":"2013","journal-title":"J Clin Oncol"},{"issue":"19","key":"2019111902453251600_B21","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.","volume":"368","author":"Maxson","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111902453251600_B22","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3324\/haematol.2009.011205","article-title":"TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.","volume":"94","author":"Kosmider","year":"2009","journal-title":"Haematologica"},{"issue":"9","key":"2019111902453251600_B23","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood-2014-03-560227","article-title":"Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.","volume":"124","author":"Malcovati","year":"2014","journal-title":"Blood"},{"issue":"12","key":"2019111902453251600_B24","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","article-title":"Clonal architecture of chronic myelomonocytic leukemias.","volume":"121","author":"Itzykson","year":"2013","journal-title":"Blood"},{"issue":"10","key":"2019111902453251600_B25","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/leu.2013.97","article-title":"SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML.","volume":"27","author":"Laborde","year":"2013","journal-title":"Leukemia"},{"issue":"11","key":"2019111902453251600_B26","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/leu.2014.125","article-title":"ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.","volume":"28","author":"Patnaik","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"2019111902453251600_B27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.2010.08381.x","article-title":"ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.","volume":"151","author":"Gelsi-Boyer","year":"2010","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111902453251600_B28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/leu.2013.35","article-title":"SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.","volume":"27","author":"Damm","year":"2013","journal-title":"Leukemia"},{"issue":"7","key":"2019111902453251600_B29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3324\/haematol.2008.005421","article-title":"Morphological evaluation of monocytes and their precursors.","volume":"94","author":"Goasguen","year":"2009","journal-title":"Haematologica"},{"issue":"11","key":"2019111902453251600_B30","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.13405","article-title":"Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.","volume":"93","author":"Mufti","year":"2008","journal-title":"Haematologica"},{"issue":"23","key":"2019111902453251600_B31","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.","volume":"25","author":"Malcovati","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111902453251600_B32","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2011.044602","article-title":"Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS).","volume":"96","author":"Malcovati","year":"2011","journal-title":"Haematologica"},{"issue":"17","key":"2019111902453251600_B33","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2009-05-222331","article-title":"Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.","volume":"114","author":"Malcovati","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2019111902453251600_B34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform.","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"issue":"5","key":"2019111902453251600_B35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data.","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"issue":"446","key":"2019111902453251600_B36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"9","key":"2019111902453251600_B37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3324\/haematol.2014.114660","article-title":"An International MDS\/MPN Working Group\u2019s perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic\/myeloproliferative neoplasms.","volume":"100","author":"Mughal","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"2019111902453251600_B38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.23702","article-title":"Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia.","volume":"89","author":"Cervera","year":"2014","journal-title":"Am J Hematol"},{"issue":"5","key":"2019111902453251600_B39","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/leu.2010.52","article-title":"Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS\/myeloproliferative neoplasms.","volume":"24","author":"Kosmider","year":"2010","journal-title":"Leukemia"},{"issue":"26","key":"2019111902453251600_B40","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes.","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111902453251600_B41","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1038\/leu.2013.160","article-title":"NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.","volume":"27","author":"Murphy","year":"2013","journal-title":"Leukemia"},{"issue":"12","key":"2019111902453251600_B42","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.leukres.2014.09.003","article-title":"Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias.","volume":"38","author":"Schuler","year":"2014","journal-title":"Leuk Res"},{"key":"2019111902453251600_B43","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1038\/bcj.2015.53","article-title":"An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.","volume":"5","author":"Padron","year":"2015","journal-title":"Blood Cancer J"},{"issue":"12","key":"2019111902453251600_B44","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2014-10-607341","article-title":"An international consortium proposal of uniform response criteria for myelodysplastic\/myeloproliferative neoplasms (MDS\/MPN) in adults.","volume":"125","author":"Savona","year":"2015","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/10\/1408\/1394777\/1408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/10\/1408\/1394777\/1408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:46:24Z","timestamp":1574131584000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/10\/1408\/35302\/Integrating-clinical-features-and-genetic-lesions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,8]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,9,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-05-714030","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,8]]}}}